Synergistic Effect of Tangeretin and Atorvastatin for Colon Cancer Combination Therapy: Targeted Delivery of These Dual Drugs Using RGD Peptide Decorated Nanocarriers

References

• ArnoldM, SierraMS, LaversanneM, SoerjomataramI, JemalA, BrayF. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. doi:10.1136/gutjnl-2015-31091226818619
   PubMed Web of Science ®Google Scholar
• LeeWS, YunSH, ChunHK, et al. Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival. Int J Colorectal Dis. 2007;22(6):699–704. doi:10.1007/s00384-006-0218-217109105
   PubMed Web of Science ®Google Scholar
• AlbertsSR, HorvathWL, SternfeldWC, et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a north central cancer treatment group Phase II study. J Clin Oncol. 2005;23(36):9243–9249. doi:10.1200/JCO.2005.07.74016230673
   PubMed Web of Science ®Google Scholar
• KemenyN. Management of liver metastases from colorectal cancer. Oncology (Williston Park). 2006;20(10):1161–1176.17024869
   PubMed Web of Science ®Google Scholar
• MuratoreA, ZorziD, BouzariH, et al. Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol. 2007;14(2):766–770. doi:10.1245/s10434-006-9146-117103261
   PubMed Web of Science ®Google Scholar
• HouX, YangC, ZhangL, et al. Killing colon cancer cells through PCD pathways by a novel hyaluronic acid-modified shell-core nanoparticle loaded with RIP3 in combination with chloroquine. Biomaterials. 2017;124:195–210. doi:10.1016/j.biomaterials.2016.12.03228199887
   PubMed Web of Science ®Google Scholar
• KotelevetsL, ChastreE, DesmaëleD, CouvreurP. Nanotechnologies for the treatment of colon cancer: from old drugs to new hope. Int J Pharm. 2016;514(1):24–40. doi:10.1016/j.ijpharm.2016.06.00527863668
   PubMed Web of Science ®Google Scholar
• Palko-LabuzA, Sroda-PomianekK, UrygaA, Kostrzewa-SuslowE, MichalakK. Anticancer activity of baicalein and luteolin studied in colorectal adenocarcinoma LoVo cells and in drug-resistant LoVo/Dx cells. Biomed Pharmacother. 2017;88:232–241. doi:10.1016/j.biopha.2017.01.05328110189
   PubMed Web of Science ®Google Scholar
• ChirumboloS, BjørklundG, LysiukR, VellaA, LenchykL, UpyrT. Targeting cancer with phytochemicals via their fine tuning of the cell survival signaling pathways. Int J Mol Sci. 2018;19(11):3568. doi:10.3390/ijms19113568
   PubMed Web of Science ®Google Scholar
• MohanaS, GanesanM, AgilanB, et al. Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer. Mol Biosyst. 2016;12(8):2458–2470. doi:10.1039/C6MB00187D27216424
   PubMedGoogle Scholar
• WesołowskaO, WiśniewskiJ, Sroda-PomianekK, et al. Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants. J Nat Prod. 2012;75(11):1896–1902. doi:10.1021/np300346823137376
   PubMed Web of Science ®Google Scholar
• PereiraCV, DuarteM, SilvaP, et al. Polymethoxylated flavones target cancer stemness and improve the antiproliferative effect of 5-fluorouracil in a 3D cell model of colorectal cancer. Nutrients. 2019;11(2):326. doi:10.3390/nu11020326
   PubMed Web of Science ®Google Scholar
• SilvaI, EstradaMF, PereiraV, et al. Polymethoxylated flavones from orange peels inhibit cell proliferation in a 3D cell model of human colorectal cancer. Nutr Cancer. 2018;70(2):257–266. doi:10.1080/01635581.2018.141247329313727
   PubMed Web of Science ®Google Scholar
• ZhengJ, ShaoY, JiangY, et al. Tangeretin inhibits hepatocellular carcinoma proliferation and migration by promoting autophagy-related BECLIN1. Cancer Manag Res. 2019;11:5231–5242. doi:10.2147/CMAR.S20097431239776
   PubMed Web of Science ®Google Scholar
• MorleyKL, FergusonPJ, KoropatnickJ. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Lett. 2007;251(1):168–178. doi:10.1016/j.canlet.2006.11.01617197076
   PubMed Web of Science ®Google Scholar
• ElhennawyMG, LinHS. Determination of tangeretin in rat plasma: assessment of its clearance and absolute oral bioavailability. Pharmaceutics. 2017;10(1):3. doi:10.3390/pharmaceutics10010003
   PubMed Web of Science ®Google Scholar
• RizwanullahM, AminS, MirSR, FakhriKU, RizviMMA. Phytochemical based nanomedicines against cancer: current status and future prospects. J Drug Target. 2018;26(9):731–752. doi:10.1080/1061186X.2017.140811529157022
   PubMed Web of Science ®Google Scholar
• MoroiM, NagayamaD, HaraF, et al. Outcome of pitavastatin versus atorvastatin therapy in patients with hypercholesterolemia at high risk for atherosclerotic cardiovascular disease. Int J Cardiol. 2020;305:139–146. doi:10.1016/j.ijcard.2020.01.00631987664
   PubMed Web of Science ®Google Scholar
• GambhireVM, SalunkheSM, GambhireMS. Atorvastatin-loaded lipid nanoparticles: antitumor activity studies on MCF-7 breast cancer cells. Drug Dev Ind Pharm. 2018;44(10):1685–1692. doi:10.1080/03639045.2018.149260529936872
   PubMed Web of Science ®Google Scholar
• WuX, SongM, QiuP, et al. Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis. Carcinogenesis. 2017;38(4):455–464. doi:10.1093/carcin/bgx01828207072
   PubMed Web of Science ®Google Scholar
• XiaoH, ZhangQ, LinY, ReddyBS, YangCS. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int J Cancer. 2008;122(9):2115–2124. doi:10.1002/ijc.2331518172863
   PubMed Web of Science ®Google Scholar
• LeeSJ, LeeI, LeeJ, ParkC, KangWK. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer. Br J Cancer. 2014;111(3):497–505. doi:10.1038/bjc.2014.28324945998
   PubMed Web of Science ®Google Scholar
• ShanD, LiJ, CaiP, et al. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells. Drug Deliv Transl Res. 2015;5(1):15–26. doi:10.1007/s13346-014-0210-225787336
   PubMed Web of Science ®Google Scholar
• ZhuS, QianL, HongM, ZhangL, PeiY, JiangY. RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells. Adv Mater. 2011;23(12):H84–9. doi:10.1002/adma.20100394421360776
   PubMed Web of Science ®Google Scholar
• BiW, LiX, BiY, et al. Novel TEMPO-PEG-RGDs conjugates remediate tissue damage induced by acute limb ischemia/reperfusion. J Med Chem. 2012;55(9):4501–4505. doi:10.1021/jm201381w22439897
   PubMed Web of Science ®Google Scholar
• LiJ, ZhangX, WangM, et al. Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration. Int J Pharm. 2016;501(1–2):112–123. doi:10.1016/j.ijpharm.2016.01.06826828670
   PubMed Web of Science ®Google Scholar
• YuanZ, YuanY, HanL, et al. Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer. Int J Nanomedicine. 2018;13:7533–7548. doi:10.2147/IJN.S17069230532537
   PubMed Web of Science ®Google Scholar
• NikME, Malaekeh-NikoueiB, AminM, et al. Liposomal formulation of galbanic acid improved therapeutic efficacy of pegylated liposomal doxorubicin in mouse colon carcinoma. Sci Rep. 2019;9(1):9527. doi:10.1038/s41598-019-45974-731267009
   PubMed Web of Science ®Google Scholar
• HanS, SunR, SuH, et al. Delivery of docetaxel using pH-sensitive liposomes based on D-α-tocopheryl poly(2-ethyl-2-oxazoline) succinate: comparison with PEGylated liposomes. Asian J Pharm Sci. 2019;14(4):391–404. doi:10.1016/j.ajps.2018.07.00532104468
   PubMed Web of Science ®Google Scholar
• YuW, LiuC, YeJ, ZouW, ZhangN, XuW. Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery. Nanotechnology. 2009;20(21):215102. doi:10.1088/0957-4484/20/21/21510219423923
   PubMed Web of Science ®Google Scholar
• ZengS, WuF, LiB, et al. Synthesis, characterization, and evaluation of a novel amphiphilic polymer RGD-PEG-Chol for target drug delivery system. ScientificWorldJournal. 2014;2014:546176. doi:10.1155/2014/54617624578646
   PubMed Web of Science ®Google Scholar
• YuW, LiuC, LiuY, ZhangN, XuW. Mannan-modified solid lipid nanoparticlesfor targeted gene delivery to alveolar macrophages. Pharm Res. 2010;27(8):1584–1596. doi:10.1007/s11095-010-0149-z20422265
   PubMed Web of Science ®Google Scholar
• ChenJ, ZhengJ, McClementsDJ, XiaoH. Tangeretin-loaded protein nanoparticles fabricated from zein/β-lactoglobulin: preparation, characterization, and functional performance. Food Chem. 2014;158:466–472. doi:10.1016/j.foodchem.2014.03.00324731371
   PubMed Web of Science ®Google Scholar
• GawdeKA, SauS, TatipartiK, et al. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers. Colloids Surf B Biointerfaces. 2018;167:8–19. doi:10.1016/j.colsurfb.2018.03.04629625422
   PubMed Web of Science ®Google Scholar
• MathurM, Devi VemulaK. Investigation of different types of nano drug delivery systems of atorvastatin for the treatment of hyperlipidemia. Drug Dev Ind Pharm. 2018;44(12):2048–2060. doi:10.1080/03639045.2018.150822530073852
   PubMed Web of Science ®Google Scholar
• LiW, WeuY, ZhaoY, ZhangS, LiuF, YangL. Content determination of polymethoxylated favones in pericarpium citri reticulatae from different cultivar origins by HPLC. China Pharm. 2019;13:30–32.
   Google Scholar
• OrtizR, CabezaL, AriasJL, et al. Poly(butylcyanoacrylate) and poly(ε-caprolactone) nanoparticles loaded with 5-fluorouracil increase the cytotoxic effect of the drug in experimental colon cancer. AAPS J. 2015;17(4):918–929. doi:10.1208/s12248-015-9761-525894746
   PubMed Web of Science ®Google Scholar
• TianL, QiaoY, LeeP, et al. Antitumor efficacy of liposome-encapsulated NVP-BEZ 235 in combination with irreversible electroporation. Drug Deliv. 2018;25(1):668–678. doi:10.1080/10717544.2018.144468329482386
   PubMed Web of Science ®Google Scholar
• ChouTC, TalalyP. A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems. J Biol Chem. 1977;252(18):6438–6442.893418
   PubMed Web of Science ®Google Scholar
• Palko-ŁabuzA, Środa-PomianekK, WesołowskaO, Kostrzewa-SusłowE, UrygaA, MichalakK. MDR reversal and pro-apoptotic effects of statins and statins combined with flavonoids in colon cancer cells. Biomed Pharmacother. 2019;109:1511–1522. doi:10.1016/j.biopha.2018.10.16930551403
   PubMed Web of Science ®Google Scholar
• MiyazawaT, NakagawaK, HarigaeT, et al. Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration. Int J Nanomedicine. 2015;10:7223–7230. doi:10.2147/IJN.S9433626664113
   PubMed Web of Science ®Google Scholar
• GuanX, ZhengX, VongCT, et al. Combined effects of berberine and evodiamine on colorectal cancer cells and cardiomyocytes in vitro. Eur J Pharmacol. 2020;875:173031. doi:10.1016/j.ejphar.2020.17303132109457
   PubMed Web of Science ®Google Scholar
• GenoveseS, EpifanoF, PreziusoF, et al. Gercumin synergizes the action of 5-fluorouracil and oxaliplatin against chemoresistant human cancer colon cells. Biochem Biophys Res Commun. 2020;522(1):95–99. doi:10.1016/j.bbrc.2019.11.06831740005
   PubMed Web of Science ®Google Scholar
• VialeM, TostoR, GiglioV, et al. Cyclodextrin polymers decorated with RGD peptide as delivery systems for targeted anti-cancer chemotherapy. Invest New Drugs. 2019;37(4):771–778. doi:10.1007/s10637-018-0711-930556100
   PubMed Web of Science ®Google Scholar
• MuruganC, RayappanK, ThangamR, et al. Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy. Sci Rep. 2016;6(1):34053. doi:10.1038/srep3405327725731
   PubMed Web of Science ®Google Scholar
• DongY, ZhangZ, FengSS. d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) modified poly(l-lactide) (PLLA) films for localized delivery of paclitaxel. Int J Pharm. 2008;350(1–2):166–171. doi:10.1016/j.ijpharm.2007.08.04317920218
   PubMed Web of Science ®Google Scholar
• WickensJM, AlsaabHO, KesharwaniP, et al. Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy. Drug Discov Today. 2017;22(4):665–680. doi:10.1016/j.drudis.2016.12.00928017836
   PubMed Web of Science ®Google Scholar
• SongS, MaoG, DuJ, ZhuX. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy. Drug Deliv. 2016;23(4):1404–1408. doi:10.3109/10717544.2015.106418626203687
   PubMed Web of Science ®Google Scholar
• HongY, CheS, HuiB, et al. Lung cancer therapy using doxorubicin and curcumin combination: targeted prodrug based, pH sensitive nanomedicine. Biomed Pharmacother. 2019;112:108614. doi:10.1016/j.biopha.2019.10861430798129
   PubMed Web of Science ®Google Scholar
• CereaM, FoppoliA, PaluganL, et al. Non-uniform drug distribution matrix system (NUDDMat) for zero-order release of drugs with different solubility. Int J Pharm. 2020;581:119217. doi:10.1016/j.ijpharm.2020.11921732165228
   PubMed Web of Science ®Google Scholar
• AkhterMH, KumarS, NomaniS. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and in vitro studies. Drug Dev Ind Pharm. 2020;1–41.
   Web of Science ®Google Scholar
• WangC, SuL, WuC, WuJ, ZhuC, YuanG. RGD peptide targeted lipid-coated nanoparticles for combinatorial delivery of sorafenib and quercetin against hepatocellular carcinoma. Drug Dev Ind Pharm. 2016;42(12):1938–1944. doi:10.1080/03639045.2016.118543527142812
   PubMed Web of Science ®Google Scholar
• LiS, WangL, LiN, LiuY, SuH. Combination lung cancer chemotherapy: design of a pH-sensitive transferrin-PEG-Hz-lipid conjugate for the co-delivery of docetaxel and baicalin. Biomed Pharmacother. 2017;95:548–555. doi:10.1016/j.biopha.2017.08.09028869892
   PubMed Web of Science ®Google Scholar
• WangJ, SuG, YinX, et al. Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor-Afatinib: in vitro and in vivo evaluation. Biomed Pharmacother. 2019;120:109493. doi:10.1016/j.biopha.2019.10949331586902
   PubMed Web of Science ®Google Scholar
• YuJ, GuY, DuKT, MihardjaS, SieversRE, LeeRJ. The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials. 2009;30(5):751–756. doi:10.1016/j.biomaterials.2008.09.05919010528
   PubMed Web of Science ®Google Scholar
• WangH, SunG, ZhangZ, OuY. Transcription activator, hyaluronic acid and tocopheryl succinate multi-functionalized novel lipid carriers encapsulating etoposide for lymphoma therapy. Biomed Pharmacother. 2017;91:241–250. doi:10.1016/j.biopha.2017.04.10428460227
   PubMed Web of Science ®Google Scholar
• ZhangR, RuY, GaoY, LiJ, MaoS. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer. Drug Des Devel Ther. 2017;11:2631–2642. doi:10.2147/DDDT.S143047
   PubMed Web of Science ®Google Scholar